Earnings Summary

Edwards Lifesciences Corp.’s revenue jumped 9.5% since last year same period to $1598.2Mn in the Q1 2024. On a quarterly growth basis, Edwards Lifesciences Corp. has generated 4.18% jump in its revenue since last 3-months.

Edwards Lifesciences Corp.’s net profit jumped 3.35% since last year same period to $351.9Mn in the Q1 2024. On a quarterly growth basis, Edwards Lifesciences Corp. has generated -4.87% fall in its net profits since last 3-months.

Edwards Lifesciences Corp.’s net profit margin fell -5.61% since last year same period to 22.02% in the Q1 2024. On a quarterly growth basis, Edwards Lifesciences Corp. has generated -8.68% fall in its net profit margins since last 3-months.

Edwards Lifesciences Corp.’s price-to-earnings ratio after this Q1 2024 earnings stands at 36.4.

Edwards Lifesciences Corp.’s earning per share (EPS) estimates for the current quarter stand at 0.69 - a 7.81% jump from last quarter’s estimates.

Edwards Lifesciences Corp.’s earning per share (EPS) estimates for the current year stand at 0.69.

Edwards Lifesciences Corp.’s earning per share (EPS) jumped 6.06% since last year same period to 0.7 in the Q2 2024. This indicates that the Edwards Lifesciences Corp. has generated 6.06% annual rate of jump in its earning per share (EPS) in the last 4 quarters.